Feb 2016 $1 M No. 6 Under $2 million 27
PLX Pharma Inc.: Raise no. 6, Feb 2016 × Investors in this round 27 investors had bought by the notice of Mar 11, 2016: 27 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $2 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Jorden · Executive Officer · CFO, Secretary Gary Mossman · Executive Officer · COO Natasha Giordano · Executive Officer, Director · Director, President, CEO Ron Zimmerman · Executive Officer · Senior Adviser Upendra Marathi · Executive Officer · Senior Vice President Bob Casale · Director Gary Balkema · Director John Hadden II · Director Kirk Calhoun · Director Michael Valentino · Director · Director, Executive Chairman Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Natasha Giordano, President. Source: SEC Form D, newest notice filed Mar 11, 2016. Read the notice at the SEC .
debt, options SEC May 2013 $9 M No. 5 $2 to $10 million 51
PLX Pharma Inc.: Raise no. 5, May 2013 × Investors in this round 51 investors had bought by the notice of Jul 8, 2013: 51 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $9 M offered
Smallest investment taken $25,000
What was sold equity
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Texas People named in the notice Gary M. Mossman · Executive Officer, Director Ronald R. Zimmerman · Executive Officer, Director Alexander F. Seelenberger · Director David R. Anderson · Director David R. Jorden · Director Lenard M. Lichtenberger · Director Michael F. Valentino · Director Peter F. Mann · Director Tim R. Black · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ronald Zimmerman, President & CEO. Source: SEC Form D, newest notice filed Jul 8, 2013. Read the notice at the SEC .
equity SEC Apr 2012 $8 M No. 4 $2 to $10 million 33
PLX Pharma Inc.: Raise no. 4, Apr 2012 × Investors in this round 33 investors had bought by the notice of Mar 19, 2013: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $8 M offered
Smallest investment taken $25,000
What was sold equity, debt
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Texas People named in the notice Gary M. Mossman · Executive Officer, Director Ronald R. Zimmerman · Executive Officer, Director Alexander F. Seelenberger · Director David R. Anderson · Director David R. Jorden · Director Lenard M. Lichtenberger · Director Michael F. Valentino · Director Tim R. Black · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ronald Zimmerman, President & CEO. Source: SEC Form D, newest notice filed Mar 19, 2013. Read the notice at the SEC .
equity, debt SEC Jul 2011 $3 M No. 3 $2 to $10 million 22
PLX Pharma Inc.: Raise no. 3, Jul 2011 × Investors in this round 22 investors had bought by the notice of Oct 5, 2011: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $7 M offered; $4 M still to sell
Smallest investment taken $25,000
What was sold equity
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Gary M. Mossman · Executive Officer, Director Ronald R. Zimmerman · Executive Officer, Director David R. Anderson · Director David R. Jorden · Director Lenard M. Lichtenberger · Director Tim R. Black · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ronald Zimmerman, President & CEO. Source: SEC Form D, newest notice filed Oct 5, 2011. Read the notice at the SEC .
equity SEC Jul 2010 $2 M No. 2 $2 to $10 million 21
PLX Pharma Inc.: Raise no. 2, Jul 2010 × Investors in this round 21 investors had bought by the notice of Aug 9, 2010: 21 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $6 M offered; $4 M still to sell
Smallest investment taken $25,000
What was sold equity
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice Gary M. Mossman · Executive Officer, Director Ronald R. Zimmerman · Executive Officer, Director David R. Anderson · Director David R. Jorden · Director Lenard M. Lichtenberger · Director Tim R. Black · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ronald R. Zimmerman, President. Source: SEC Form D, newest notice filed Aug 9, 2010. Read the notice at the SEC .
equity SEC Jan 2009 $3 M No. 1 $2 to $10 million 26
PLX Pharma Inc.: Raise no. 1, Jan 2009 × Investors in this round 26 investors had bought by the notice of Jul 9, 2009: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken $24,960
What was sold equity
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Texas People named in the notice David Anderson · Director David Jorden · Director Lenard Lichtenberger · Director Tim Black · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Ronald R. Zimmerman, President & CEO. Source: SEC Form D, newest notice filed Jul 9, 2009. Read the notice at the SEC .
equity SEC